| scholarly article | Q13442814 |
| P50 | author | Kohji Moriishi | Q38326520 |
| P2093 | author name string | Suzuki K | |
| Suzuki R | |||
| Ishii K | |||
| Matsuura Y | |||
| Miyamura T | |||
| Tani H | |||
| Aizaki H | |||
| Whitt MA | |||
| Kimura-Someya T | |||
| Robison CS | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Fusion-competent vaccines: broad neutralization of primary isolates of HIV | Q56765810 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 263-275 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Characterization of pseudotype VSV possessing HCV envelope proteins | |
| P478 | volume | 286 |
| Q45722093 | A model for the study of hepatitis C virus entry |
| Q45384607 | A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein |
| Q36889041 | A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies |
| Q34009510 | A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection |
| Q37798816 | Advances and challenges in studying hepatitis C virus in its native environment |
| Q40039979 | Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins. |
| Q54988623 | Animal Models to Study Hepatitis C Virus Infection. |
| Q43049376 | Another putative receptor for hepatitis C virus |
| Q40285451 | Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs. |
| Q27486090 | Blockade of virus infection by human CD4+ T cells via a cytokine relay network |
| Q27480351 | CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection |
| Q29619745 | CD81 is required for hepatitis C virus glycoprotein-mediated viral infection |
| Q36385222 | Cell entry of hepatitis C virus |
| Q37383882 | Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein |
| Q30353044 | Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1. |
| Q40539381 | Characterization of functional hepatitis C virus envelope glycoproteins. |
| Q40228962 | Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins |
| Q38957571 | Characterization of pH-sensitive molecular switches that trigger the structural transition of vesicular stomatitis virus glycoprotein from the postfusion state toward the prefusion state |
| Q40100844 | Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses |
| Q27472885 | Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins |
| Q37596447 | Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer |
| Q40605486 | Comparison of serum sensitivities of pseudotype retroviruses produced from newly established packaging cell lines of human and feline origins |
| Q24604967 | Conserved eukaryotic fusogens can fuse viral envelopes to cells |
| Q90160161 | Crystal structure of Mokola virus glycoprotein in its post-fusion conformation |
| Q47568014 | Current status on the development of pseudoviruses for enveloped viruses |
| Q37201846 | Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems |
| Q24296260 | DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 |
| Q35679152 | Development and Applications of VSV Vectors Based on Cell Tropism |
| Q36655280 | Development of novel entry inhibitors targeting emerging viruses |
| Q36198667 | Development of prophylactic and therapeutic vaccines against hepatitis C virus |
| Q27472930 | Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype |
| Q38046287 | Entry and replication of recombinant hepatitis C viruses in cell culture |
| Q36974675 | Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. |
| Q40344741 | Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1 |
| Q33657931 | Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines |
| Q27472940 | Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector |
| Q38707906 | Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection |
| Q24551041 | Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR |
| Q27477687 | Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles |
| Q52661702 | Hepatitis C virus: Morphogenesis, infection and therapy. |
| Q39470519 | High-throughput screening of viral entry inhibitors using pseudotyped virus |
| Q24338469 | Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein |
| Q33712786 | Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screening |
| Q27491029 | In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes |
| Q24673768 | Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes |
| Q27472900 | Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry |
| Q27490958 | Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus |
| Q50777152 | Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions. |
| Q35669529 | Mechanisms of hepatitis C virus infection |
| Q27489898 | Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry |
| Q35012894 | No false start for novel pseudotyped vectors |
| Q29620681 | Novel insights into hepatitis C virus replication and persistence |
| Q59354132 | Oenothein B, dimeric hydrolysable tannin inhibiting HCV invasion from Oenothera erythrosepala |
| Q27477612 | Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein |
| Q40532515 | Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin |
| Q39908614 | Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. |
| Q40220842 | Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein |
| Q43031474 | Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C. |
| Q36933791 | Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle |
| Q40585135 | Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment |
| Q27481021 | Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins |
| Q38324768 | Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus |
| Q52358301 | Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein. |
| Q27481034 | Studying Hepatitis C Virus: Making the Best of a Bad Virus |
| Q27478383 | Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells |
| Q36871730 | TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis |
| Q40181096 | Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes |
| Q24307963 | The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus |
| Q37422843 | The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system |
| Q39713991 | Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test |
| Q38081966 | Virus-like particle-based vaccines against hepatitis C virus infection. |
| Q78318877 | [Interaction of the hepatitis C virus with the cellular membrane] |
Search more.